March 11, 2026

Perceptions of Quality of Life for Women Pregnant During a Cancer Diagnosis: A Review of the Literature

The rising trend of delaying childbirth among women has critical implications for cancer diagnoses during pregnancy, shedding light on overlooked QOL concerns.

JADPRO

March 05, 2026

Why One Number Isn’t Enough for Patients

Adding a comparison number may help patients interpret risk and make better decisions.

Conexiant

March 03, 2026

HPV Uptake Grows Over Time

Clinical trial finds that, while multicomponent strategy did not significantly boost HPV vaccination at fixed time points, initiation rates improved steadily over time

Conexiant

February 27, 2026

Cervical Cancer Is Preventable – So Why Do We Miss It?

A gynecologic oncologist explores new diagnostic priorities

The Pathologist

February 25, 2026

Can Induction Improve Survival in High-Risk, Locally Advanced Cervical Cancer?

Rates of overall and progression-free survival for locally advanced cervical cancer have risen significantly since 2024, when the FDA approved the use of pembrolizumab (brand name Keytruda) with chemoradiation for stage 3-4A disease.

Roswell Park Comprehensive Cancer Center

February 17, 2026

Hospital Prices Posted. Few Patients Look.

Federal rules require hospitals to post prices so patients can shop. Instead, insurers and providers use the data to negotiate what they get paid.

KFF Health News

February 17, 2026

Exercise Matters Following Cancer

Postdiagnosis physical activity was associated with lower cancer mortality across several cancer types.

Conexiant

February 06, 2026

Tracking Opioid Refills After Surgery

Researchers evaluated perioperative and postdischarge factors associated with opioid refill prescriptions during the first 90 days after inpatient otolaryngology–head and neck surgery.

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

October 17, 2023

Can Younger Women With Hormone Receptor–Positive Breast Cancer Safely Pause Endocrine Therapy to Pursue Pregnancy?

Preserving fertility is a driving concern for many young women with breast cancer. Many of these women have hormone receptor–positive breast cancer and are treated with adjuvant endocrine therapy for ...

The ASCO Post